Product guide · Restricted substance
Nucleon Nutrition MOTS-c 10 mg peptide
Peptide product from Nucleon Nutrition. This guide sets out what the manufacturer states about the composition of Nucleon Nutrition MOTS-c 10 mg peptide, what independent research says about its main ingredient, and the safety and regulatory points that apply. It contains substances that are not authorised as food or medicine in the EU. This guide is educational: it does not recommend use and gives no directions for use.
Back to the product- Named ingredients
- 1
- Amounts stated
- All
- Status
- Restricted substance
- Evidence summaries
- 1
Overview
Manufacturer informationNucleon Nutrition MOTS-c 10 mg peptide contains MOTS-C: 10 mg, as stated in the product title.
Ingredients & composition
Manufacturer information| Ingredient | Amount |
|---|---|
| MOTS-C | 10 mg (as stated in the product title) |
Scientific background
Independent researchMOTS-c
MOTS-c is a short peptide encoded by mitochondrial DNA and studied for its role in metabolism1.
Research evidence
Independent researchMOTS-c
In mice, MOTS-c improved insulin sensitivity and reduced diet-induced obesity1. There are no published controlled trials in humans.
Evidence limitations
Independent researchNo published study has tested this specific product; the research summarised here concerns the ingredient itself.
MOTS-c
Evidence is limited to animal and cell studies.
Safety & potential risks
Independent researchMOTS-c
Human safety data are lacking. Reviewers describe a "gray market" of unapproved peptides sold directly to consumers outside regulatory oversight, with uncertain purity and safety2.
Regulatory status
Contains a peptide that is not authorised as food (including food supplements) or as a medicinal product in the EU. No dosing information for human use is provided.
Scientific references
- Lee C, Zeng J, Drew BG, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 2015;21:443-454. PubMed 25738459
- Mendias CL, Awan TM. Safety and efficacy of approved and unapproved peptide therapies for musculoskeletal injuries and athletic performance. Sports Med. 2026;56:1921-1935. PubMed 41966639
- Directive 2001/83/EC on the Community code relating to medicinal products for human use. Official Journal of the European Union. Source
- Regulation (EU) 2015/2283 on novel foods. Official Journal of the European Union. Source
- World Anti-Doping Agency. The Prohibited List (current edition). Source
Sources checked against PubMed, Crossref or the official publisher on 2026-11-04. Manufacturer information is taken from the product's own data and has not been independently tested.
The product
Nucleon Nutrition MOTS-c 10 mg peptide
€55,90